FGF23 and metabolic disease: Mechanistic studies revealed that the FGF23/α-klotho axis could directly induce diabetes by affecting the intracellular pathway or α-carboxylase axis to regulate the fat content and distribution in hepatocytes and skeletal muscle cells [38] and indirectly alter glucose tolerance through the induction of calcium and phosphorus metabolism disorders through phosphorus modulation [39].